July 2024 - Plan Health

Home
Overview
Our Strengths
Our Values
Get Started

Articles

The rising costs of dementia medications, particularly Lecanemab priced at $26,500 annually, pose significant challenges for Medicare, which may face pressure to restrict coverage or raise premiums.

Newsweek article... Read More

by simonhenry
July 29, 2024
0